- Home
- VMD vs TRDA Comparison
VMD vs TRDA Comparison
Compare VMD & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMD
- TRDA
- Stock Information
- Founded
- VMD 2006
- TRDA 2016
- Country
- VMD United States
- TRDA United States
- Employees
- VMD N/A
- TRDA N/A
- Industry
- VMD
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- VMD
- TRDA Health Care
- Exchange
- VMD Nasdaq
- TRDA Nasdaq
- Market Cap
- VMD 273.5M
- TRDA 220.1M
- IPO Year
- VMD N/A
- TRDA 2021
- Fundamental
- Price
- VMD $7.10
- TRDA $5.19
- Analyst Decision
- VMD
- TRDA Strong Buy
- Analyst Count
- VMD 0
- TRDA 3
- Target Price
- VMD N/A
- TRDA $25.67
- AVG Volume (30 Days)
- VMD 317.1K
- TRDA 217.3K
- Earning Date
- VMD 08-06-2025
- TRDA 08-06-2025
- Dividend Yield
- VMD N/A
- TRDA N/A
- EPS Growth
- VMD 47.14
- TRDA N/A
- EPS
- VMD 0.34
- TRDA N/A
- Revenue
- VMD $240,884,000.00
- TRDA $79,476,000.00
- Revenue This Year
- VMD $17.35
- TRDA N/A
- Revenue Next Year
- VMD $12.87
- TRDA N/A
- P/E Ratio
- VMD $20.97
- TRDA N/A
- Revenue Growth
- VMD 17.11
- TRDA N/A
- 52 Week Low
- VMD $5.93
- TRDA $4.98
- 52 Week High
- VMD $9.81
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- VMD 65.58
- TRDA 30.53
- Support Level
- VMD $5.93
- TRDA $4.98
- Resistance Level
- VMD $6.41
- TRDA $6.04
- Average True Range (ATR)
- VMD 0.20
- TRDA 0.44
- MACD
- VMD 0.09
- TRDA -0.07
- Stochastic Oscillator
- VMD 95.51
- TRDA 11.48
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.